Safety & Warnings

Impedance Spectroscopy for Biofouling Detection

Electrochemical Impedance Spectroscopy (EIS) is a critical technology used in modern CGMs (Medtronic Guardian, Dexcom G7) to detect and compensate for biofouling—the accumulation of proteins on the sensor surface that degrades accuracy.

Key Mechanisms:

  • High-frequency AC signals check membrane integrity.
  • Low-frequency AC signals measure diffusion resistance caused by the body's immune response.

Applications:

  • Auto-Calibration: EIS data allows algorithms to adjust for sensitivity loss without fingersticks.
  • Artifact Rejection: It distinguishes between true hypoglycemia and "compression lows" (pressure-induced signal drops during sleep).
  • Safety: It detects sensor pull-outs and failure states.

While effective, EIS adds computational complexity and power drain to transmitters, and remains challenged by the chaotic "run-in" period immediately following sensor insertion.

2 min read
Advanced
2 glossary terms
1 citations

Introduction to Impedance Spectroscopy

Electrochemical Impedance Spectroscopy (EIS) is a non-invasive diagnostic technique used to detect biofouling in Continuous Glucose Monitors (CGMs). Biofouling refers to the accumulation of proteins and other substances on the sensor surface, leading to decreased accuracy and reliability of glucose readings [1].

Principles of EIS

EIS operates by applying a small amplitude AC signal to the sensor and measuring the resulting current. The impedance spectrum is then analyzed to determine the presence of biofouling. The technique utilizes two primary mechanisms:

  • High-frequency AC signals assess the integrity of the sensor membrane, ensuring its stability and functionality.
  • Low-frequency AC signals measure the diffusion resistance caused by the body's immune response, affecting the sensor's ability to accurately detect glucose levels.

Applications of EIS in CGMs

The integration of EIS in CGMs offers several benefits:

  • Improved accuracy: EIS enables the detection of biofouling, allowing for adjustments to be made to maintain accurate glucose readings [2].
  • Enhanced reliability: EIS helps to identify sensor failures and alerts the user to potential issues, ensuring timely intervention and maintenance [3].
  • Increased user convenience: By reducing the need for frequent calibrations, EIS enhances the overall user experience and adherence to CGM therapy [4].

Challenges and Limitations

While EIS significantly enhances the performance of CGMs, it also introduces additional computational complexity and power consumption. Furthermore, the technique faces challenges during the initial

References

  1. Method and apparatus for providing sensor diagnostics (Medtronic Patent)Source

Was this article helpful?

Explore More Topics

Continue your CGM research with related categories